Clinical Trial Update: Can COX-2 Inhibitor Decrease Stricture Recurrence After Direct Vision Internal Urethrotomy? [NA]

View source ↗

Summary

A clinical trial is evaluating whether a COX-2 inhibitor (meloxicam) can reduce stricture recurrence after direct vision internal urethrotomy and is currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urethral Stricture

Drugs mentioned

• MELOXICAM (MELOXICAM)

Snippet

Sponsor: New Valley University | Conditions: COX-2 Inhibitor, Meloxicam | NA | Status: RECRUITING